DuPont de Nemours is a specialty materials company that has spent the last two years dismantling itself into a leaner, higher-margin franchise. The second quarter is the first clean read on what the new DuPont actually earns, and it is a read that matters because the prior-year comparison no longer includes the businesses that the company has already separated. The Electronics Business exited as a standalone public company in late 2025, and the Aramids unit left for a TJC portfolio company this spring, leaving a two-segment business anchored in healthcare, water, and industrial technologies.
The strategic tension sits in the gap between that cleaner structure and the earnings it produces. Segment operating EBITDA (the earnings measure the chief operating decision maker uses) came in at $471 million in the second quarter, up 5 percent from a year ago. Net income available to common stockholders reached $143 million, up from $59 million. The stock split one-for-three in June, and the board has a $2 billion repurchase authorization that it is working through at a pace of roughly $250 million a quarter.
This quarter the evidence points in one direction: the new DuPont is growing low single digits and converting a meaningful share of it into cash. Operating cash flow from continuing operations was $632 million in the first half. The question the next two to three quarters resolve is whether the restructuring program can bend the cost curve fast enough for the buyback to do real work on a shrinking share count, and the program carries $100 million to $150 million in expected pre-tax savings.